| Literature DB >> 32155695 |
Imran Ali1,2, Mosa Alsehli1, Luciana Scotti3, Marcus Tullius Scotti3, Shang-Ting Tsai4,5, Ruei-Siang Yu4,6, Ming Fa Hsieh4,5, Jung-Chih Chen7.
Abstract
Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives.Entities:
Keywords: approved nano-medicines; future perspectives; merits and demerits; polymeric nanoparticles; theranostic cancer treatment
Year: 2020 PMID: 32155695 DOI: 10.3390/polym12030598
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329